US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 5.565
  • +0.025+0.45%
Trading Dec 2 13:26 ET
381.47MMarket Cap-1456P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-99.59%416K
-101.04%-1.02M
24.10%88.64M
1,612.94%380.79M
395.54%108.45M
29,666.09%102.69M
98.22M
71.43M
22.23M
21.89M
Operating revenue
--0
-99.44%605K
34.42%113.66M
1,491.77%431.43M
376.75%126.61M
20,350.46%111.86M
--108.41M
--84.55M
--27.1M
--26.56M
Cost of revenue
-84.50%809K
32.94%7.42M
2,103.41%116.41M
750.02%25.44M
231.80%9.36M
2,933.72%5.22M
5.58M
5.28M
2.99M
2.82M
Gross profit
-100.40%-393K
-109.11%-8.44M
-141.97%-27.76M
1,747.20%355.35M
419.77%99.09M
56,243.93%97.48M
92.64M
66.15M
19.24M
19.06M
Operating expense
-50.40%39.07M
-37.88%44.99M
38.37%94.37M
43.51%316.54M
52.62%97.16M
43.57%78.76M
33.51%72.44M
42.63%68.2M
166.76%220.58M
124.82%63.66M
Selling and administrative expenses
-63.41%17.83M
-50.11%21.65M
31.25%57.76M
48.16%188.36M
27.90%52.24M
62.72%48.72M
44.67%43.39M
67.01%44.01M
226.53%127.13M
173.74%40.84M
Research and development costs
-29.30%21.24M
-19.62%23.35M
51.32%36.61M
37.17%128.19M
96.88%44.91M
20.56%30.04M
19.72%29.04M
12.71%24.19M
112.19%93.45M
70.32%22.81M
Operating profit
-310.78%-39.46M
-364.52%-53.44M
-5,848.86%-122.13M
119.27%38.8M
104.34%1.93M
134.23%18.72M
137.23%20.2M
95.71%-2.05M
-143.49%-201.34M
-57.49%-44.59M
Net non-operating interest income expense
-25.87%3.1M
4.68%4.07M
16.35%4.33M
276.49%16.16M
38.45%4.37M
595.34%4.18M
866.92%3.89M
2,738.17%3.72M
11,819.44%4.29M
10,423.33%3.16M
Non-operating interest income
-25.87%3.1M
4.68%4.07M
16.35%4.33M
276.49%16.16M
38.45%4.37M
595.34%4.18M
866.92%3.89M
2,738.17%3.72M
11,819.44%4.29M
10,423.33%3.16M
Other net income (expense)
-7,347.54%-36.34M
-28,707.41%-23.33M
-185.11%-747K
-19.78%-660K
124.82%171K
-345.23%-488K
-92.86%-81K
-1,278.95%-262K
89.56%-551K
-1,067.80%-689K
Special income (charges)
---36.2M
---22.85M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--0
--22.85M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
--36.2M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
71.11%-141K
-496.30%-483K
-185.11%-747K
-19.78%-660K
124.82%171K
-345.23%-488K
-92.86%-81K
-1,278.95%-262K
89.56%-551K
-1,067.80%-689K
Income before tax
-424.41%-72.7M
-402.83%-72.7M
-8,549.82%-118.55M
127.48%54.3M
115.37%6.48M
141.59%22.41M
144.55%24.01M
102.94%1.4M
-124.72%-197.6M
-48.62%-42.13M
Income tax
0
0
242.35%242K
549.35%5.03M
201.38%1.75M
1,314.40%1.52M
1,010.92%1.93M
-216.44%-170K
774K
579K
Net income
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Net income continuous Operations
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Minority interest income
Net income attributable to the parent company
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Basic earnings per share
-445.16%-1.07
-424.24%-1.07
-8,850.00%-1.75
121.53%0.73
110.77%0.07
133.70%0.31
135.48%0.33
102.15%0.02
-112.87%-3.39
-26.62%-0.65
Diluted earnings per share
-456.67%-1.07
-445.16%-1.07
-8,850.00%-1.75
120.65%0.7
110.77%0.07
132.61%0.3
133.33%0.31
102.15%0.02
-112.87%-3.39
-26.62%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue -99.59%416K -101.04%-1.02M 24.10%88.64M 1,612.94%380.79M 395.54%108.45M 29,666.09%102.69M 98.22M 71.43M 22.23M 21.89M
Operating revenue --0 -99.44%605K 34.42%113.66M 1,491.77%431.43M 376.75%126.61M 20,350.46%111.86M --108.41M --84.55M --27.1M --26.56M
Cost of revenue -84.50%809K 32.94%7.42M 2,103.41%116.41M 750.02%25.44M 231.80%9.36M 2,933.72%5.22M 5.58M 5.28M 2.99M 2.82M
Gross profit -100.40%-393K -109.11%-8.44M -141.97%-27.76M 1,747.20%355.35M 419.77%99.09M 56,243.93%97.48M 92.64M 66.15M 19.24M 19.06M
Operating expense -50.40%39.07M -37.88%44.99M 38.37%94.37M 43.51%316.54M 52.62%97.16M 43.57%78.76M 33.51%72.44M 42.63%68.2M 166.76%220.58M 124.82%63.66M
Selling and administrative expenses -63.41%17.83M -50.11%21.65M 31.25%57.76M 48.16%188.36M 27.90%52.24M 62.72%48.72M 44.67%43.39M 67.01%44.01M 226.53%127.13M 173.74%40.84M
Research and development costs -29.30%21.24M -19.62%23.35M 51.32%36.61M 37.17%128.19M 96.88%44.91M 20.56%30.04M 19.72%29.04M 12.71%24.19M 112.19%93.45M 70.32%22.81M
Operating profit -310.78%-39.46M -364.52%-53.44M -5,848.86%-122.13M 119.27%38.8M 104.34%1.93M 134.23%18.72M 137.23%20.2M 95.71%-2.05M -143.49%-201.34M -57.49%-44.59M
Net non-operating interest income expense -25.87%3.1M 4.68%4.07M 16.35%4.33M 276.49%16.16M 38.45%4.37M 595.34%4.18M 866.92%3.89M 2,738.17%3.72M 11,819.44%4.29M 10,423.33%3.16M
Non-operating interest income -25.87%3.1M 4.68%4.07M 16.35%4.33M 276.49%16.16M 38.45%4.37M 595.34%4.18M 866.92%3.89M 2,738.17%3.72M 11,819.44%4.29M 10,423.33%3.16M
Other net income (expense) -7,347.54%-36.34M -28,707.41%-23.33M -185.11%-747K -19.78%-660K 124.82%171K -345.23%-488K -92.86%-81K -1,278.95%-262K 89.56%-551K -1,067.80%-689K
Special income (charges) ---36.2M ---22.85M ---- ---- ---- --0 --0 ---- ---- ----
-Less：Restructuring and merger&acquisition --0 --22.85M ---- ---- ---- --0 --0 ---- ---- ----
-Less:Other special charges --36.2M ---- ---- ---- ---- ---- ---- ---- ---- ----
Other non- operating income (expenses) 71.11%-141K -496.30%-483K -185.11%-747K -19.78%-660K 124.82%171K -345.23%-488K -92.86%-81K -1,278.95%-262K 89.56%-551K -1,067.80%-689K
Income before tax -424.41%-72.7M -402.83%-72.7M -8,549.82%-118.55M 127.48%54.3M 115.37%6.48M 141.59%22.41M 144.55%24.01M 102.94%1.4M -124.72%-197.6M -48.62%-42.13M
Income tax 0 0 242.35%242K 549.35%5.03M 201.38%1.75M 1,314.40%1.52M 1,010.92%1.93M -216.44%-170K 774K 579K
Net income -447.98%-72.7M -429.35%-72.7M -7,652.00%-118.79M 124.84%49.27M 111.08%4.73M 138.87%20.89M 140.83%22.07M 103.29%1.57M -125.60%-198.38M -50.66%-42.7M
Net income continuous Operations -447.98%-72.7M -429.35%-72.7M -7,652.00%-118.79M 124.84%49.27M 111.08%4.73M 138.87%20.89M 140.83%22.07M 103.29%1.57M -125.60%-198.38M -50.66%-42.7M
Minority interest income
Net income attributable to the parent company -447.98%-72.7M -429.35%-72.7M -7,652.00%-118.79M 124.84%49.27M 111.08%4.73M 138.87%20.89M 140.83%22.07M 103.29%1.57M -125.60%-198.38M -50.66%-42.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -447.98%-72.7M -429.35%-72.7M -7,652.00%-118.79M 124.84%49.27M 111.08%4.73M 138.87%20.89M 140.83%22.07M 103.29%1.57M -125.60%-198.38M -50.66%-42.7M
Basic earnings per share -445.16%-1.07 -424.24%-1.07 -8,850.00%-1.75 121.53%0.73 110.77%0.07 133.70%0.31 135.48%0.33 102.15%0.02 -112.87%-3.39 -26.62%-0.65
Diluted earnings per share -456.67%-1.07 -445.16%-1.07 -8,850.00%-1.75 120.65%0.7 110.77%0.07 132.61%0.3 133.33%0.31 102.15%0.02 -112.87%-3.39 -26.62%-0.65
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data